Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Qidong 1992-2000102677.40.44120161.6101098.4
China - Shangai 1992-1995328574.90.001010.03284100.0
China - Tianjin 1991-1999250870.50.016070.3250199.7
Cuba 1994-199579062.029.12300423429.655670.4
India - Barshi 1993-20004991.80.000000.049100.0
India - Bhopal 1991-19955280.81.911111325.03975.0
India - Karunagappally 1991-19973976.92.610012.63897.4
India - Mumbai 1992-1994129975.75.97660826.3121793.7
Philippines - Manila 1994-199512487.90.002012116.910383.1
Singapore 1993-1997183197.20.23669784.3175395.7
Republic of Korea - Busan 1996-2001196388.93.364170814.1188295.9
Republic of Korea - Incheon 1997-2001116886.73.94501463.9112296.1
Republic of Korea - Seoul 1993-1997407187.92.811224313568.7371591.3
Thailand - Chiang Mai 1993-199721983.10.002902913.219086.8
Thailand - Khon Kaen 1993-199714367.10.003142.813997.2
Thailand - Lampang 1990-200025083.60.410010.424999.6
Thailand - Songkhla 1990-199923291.40.002902912.520387.5
Turkey - Izmir 1995-199734992.80.003251.434498.6
Uganda - Kampala 1993-19975967.80.0081915.35084.7
Zimbabwe - Harare 1993-19977676.310.5810911.86788.2



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period